Director, Product Development & Marketing, Broad Institute Genomics PlatformBiography
Andrew Barry is the Director of Product Development for the Broad Institute Genomics Platform. Andrew developed techniques for the application of NGS to studying protein interactions using phage display while earning an MS in Biomedical engineering from Tufts University. Concurrently, Andrew spent 9 years working for the Broad Institute, developing technologies for the implementation and scale-up of next generation sequencing, before leaving to work in the industrial sector. Working for Caliper Life Sciences (later acquired by PerkinElmer) he held various positions in product management, strategic marketing, and biology R&D before re-joining the Broad Institute in 2014. In his current role, Andrew is responsible for bringing the Broad Institute's genomics capabilities to the scientific community in the form of Broad Genomic Services.